Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Capital One
COF
|
+$445M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$405M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$387M |
| 4 |
Johnson & Johnson
JNJ
|
+$256M |
| 5 |
Procter & Gamble
PG
|
+$170M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$536M |
| 2 |
NVIDIA
NVDA
|
+$471M |
| 3 |
X
US Steel
X
|
+$421M |
| 4 |
JPMorgan Chase
JPM
|
+$237M |
| 5 |
Deere & Co
DE
|
+$235M |
Sector Composition
| 1 | Technology | 20.97% |
| 2 | Financials | 18.52% |
| 3 | Industrials | 12.24% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Healthcare | 9.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Middlefield Banc Corp
MBCN
$238M
| $2.56M | ﹤0.01% |
85,077
+2,516
| +3% | +$75.8K |
|
2702
Opko Health
OPK
$1.12B
| $2.55M | ﹤0.01% |
1,929,683
-292,829
| -13% | -$387K |
|
2703
3D Systems Corporation
DDD
$272M
| $2.54M | ﹤0.01% |
1,647,242
-71,047
| -4% | -$109K |
|
2704
Mineralys Therapeutics
MLYS
$2.99B
| $2.54M | ﹤0.01% |
187,384
+106,592
| +132% | +$1.44M |
|
2705
8x8 Inc
EGHT
$285M
| $2.52M | ﹤0.01% |
1,284,109
-315,227
| -20% | -$618K |
|
2706
AerCap
AER
$21.7B
| $2.5M | ﹤0.01% |
21,409
-6
| -0% | -$702 |
|
|
BRT
2707
BRT Apartments
BRT
$290M
| $2.49M | ﹤0.01% |
159,462
+781
| +0.5% | +$12.2K |
|
2708
MoonLake Immunotherapeutics
MLTX
$3.44B
| $2.49M | ﹤0.01% |
52,719
-775
| -1% | -$36.6K |
|
|
NUTX
2709
Nutex Health
NUTX
$462M
| $2.49M | ﹤0.01% |
19,987
+12,941
| +184% | +$1.61M |
|
2710
Biote Corp
BTMD
$104M
| $2.48M | ﹤0.01% |
617,593
-34,658
| -5% | -$139K |
|
2711
Takeda Pharmaceutical
TAK
$48.3B
| $2.47M | ﹤0.01% |
159,716
-17,290
| -10% | -$267K |
|
2712
Douglas Elliman
DOUG
$230M
| $2.47M | ﹤0.01% |
1,063,743
+37,970
| +4% | +$88.1K |
|
|
GRAL
2713
GRAIL, Inc. Common Stock
GRAL
$1.28B
| $2.46M | ﹤0.01% |
47,924
+13
| +0% | +$668 |
|
|
BRDG
2714
DELISTED
Bridge Investment Group
BRDG
| $2.46M | ﹤0.01% |
246,000
| – | – |
|
2715
ATS Corp
ATS
$2.58B
| $2.46M | ﹤0.01% |
77,062
+33,489
| +77% | +$1.07M |
|
|
BPMC
2716
DELISTED
Blueprint Medicines
BPMC
| $2.42M | ﹤0.01% |
18,907
+303
| +2% | +$38.8K |
|
2717
Grupo Aeroportuario Centro Norte
OMAB
$5.17B
| $2.41M | ﹤0.01% |
22,866
+597
| +3% | +$63K |
|
|
NEXN
2718
Nexxen International
NEXN
$606M
| $2.4M | ﹤0.01% |
230,160
-33,704
| -13% | -$351K |
|
2719
Amylyx Pharmaceuticals
AMLX
$1.05B
| $2.4M | ﹤0.01% |
373,739
+250,163
| +202% | +$1.6M |
|
2720
Southern California Bancorp
BCAL
$558M
| $2.39M | ﹤0.01% |
151,439
+43,424
| +40% | +$684K |
|
2721
USCB Financial Holdings
USCB
$349M
| $2.38M | ﹤0.01% |
143,707
+27,001
| +23% | +$447K |
|
2722
AudioCodes
AUDC
$284M
| $2.36M | ﹤0.01% |
240,340
+16,841
| +8% | +$165K |
|
2723
SoundThinking
SSTI
$160M
| $2.36M | ﹤0.01% |
180,411
+21,818
| +14% | +$285K |
|
2724
AMCON Distributing
DIT
$76.1M
| $2.33M | ﹤0.01% |
21,182
| – | – |
|
2725
Eletrobras Common Shares
EBR
$19.1B
| $2.33M | ﹤0.01% |
313,359
+118,949
| +61% | +$884K |
|